Merck Message Board - Msg: 4077027

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Merck

MRK 101.07

-0.8%

Dec 2 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rob L. who wrote (698)	4/15/1998 7:48:00 PM
From: one putt	Read Replies (2) of 1580

<<The stock had no reaction to FDA approval of its new drug.>> Perhaps this is because they did not receive approval from the FDA. Of course it is very likely that it will happen, I have seen it take up to six months to receive an approval following an approvable letter from the FDA. One particular stock I have been following for quite some time (Pharmos, PARS - NASDAQ) received FDA approval for two new opthalmological drugs at the same time, with huge potential, but had very little impact on the current trading price. Perhaps this is because the intial anticipation was already accounted for in the price. Until Merck begins generating revenues from this new product, the stock price will likely not reflect even FDA approval. Craig~

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next